Brief: Healius Ltd Board Recommends Shareholders Reject Australian Clinical Labs' Offer

Australian Clinical Labs

04/05/2023 02:01

May 4 (Reuters) - Australian Clinical Labs Ltd  ACL.AX :
    * BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT THE OFFER
BY
AUSTRALIAN CLINICAL LABS
    * BOARD IS NOT OPPOSED TO ENGAGING IN DISCUSSIONS WITH ACL,
OR
ANOTHER PARTY, IN RELATION TO A CONTROL TRANSACTION OR MERGER
PROPOSAL
    * UNSOLICITED CONDITIONAL OFFER "OPPORTUNISTICALLY TIMED"
AND
WOULD RESULT IN AN "UNFAIR TRANSFER OF VALUE" FROM CO'S
SHAREHOLDERS TO ACL

Source text for Eikon:  ID:nASX81ggM8 
Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))